Method and device for drug screening
AssigneeShanghai Lide Biotech Co., Ltd.
InventorsDanyi Wen, Feifei Zhang
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for determining the efficacy of anti-tumor drugs in a time-efficient manner, comprising the following steps: (1) transferring a primary tumor cell into an implant device; (2) implanting the implant device comprising the primary tumor cell into an animal; (3) administering a candidate drug to the animal; (4) determining the sensitivity of the tumor cell to the candidate drug.
Claims21
A method for determining the sensitivity of a primary tumor cell to an anti-tumor drug, comprising the following steps:
- (1) transferring a primary tumor cell into an implant device;
- (2) implanting the implant device comprising the primary tumor cell into an animal;
- (3) administering a candidate drug to the animal;
- (4) determining the sensitivity of the tumor cell to the candidate drug.
A kit for determining the sensitivity of a primary tumor cell to an anti-tumor drug, comprising an implant device, said implant device is a tubular device having a molecular weight cut-off value of about 500,000 Dalton.
(canceled)
Dependencies are inferred from the claim text.